Kawasaki disease – experience of Pediatric University Hospital, Sofia, Bulgaria, 1993–2014. Part II: cardiovascular manifestations and treatment

References

• Jamieson N, Singh-Grewal D. Kawasaki disease: a clinician's update. Int J Pediatrics. 2013 [cited 2017 May 8];2013:645391. DOI: 10.1155/2013/645391
   PubMedGoogle Scholar
• Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–941.
   PubMed Web of Science ®Google Scholar
• Burns J, Glode M. Kawasaki syndrome. Lancet. 2004;364(9433):533–544.
   PubMed Web of Science ®Google Scholar
• Newburger JW. Kawasaki disease. Curr Treat Options Cardiovasc Med. 2000;2:227–236.
   PubMedGoogle Scholar
• Okura N, Okuda T, Shiotani S, et al. Sudden death as a late sequel of Kawasaki disease: postmortem CT demonstration of coronary artery aneurysm. Forensic Sci Int. 2013;225(1–3):85–88.
   PubMed Web of Science ®Google Scholar
• Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334(16):1039–1044.
   PubMed Web of Science ®Google Scholar
• Shah V, Christov G, Mukasa T, et al. Cardiovascular status after Kawasaki disease in the UK. Heart. 2015;101(20):1646–1655.
   PubMed Web of Science ®Google Scholar
• Telcharova-Mihaylovska A, Nikolova I, Marinov R, et al. Kawasaki disease – experience of Pediatric University Hospital, Sofia, Bulgaria, 1993–2014. Part I: clinical manifestations. Biotechnol Biotechnol Equip. Forthcoming 2017; Available from: https://doi.org/10.1080/13102818.2017.1316683
   Web of Science ®Google Scholar
• Momenah Т, Sanatani S, Potts J, et al. Kawasaki disease in the older child. Pediatrics. 1998 [cited 2017 May 8];102(1):e7. Available from:http://www.pediatrics.org/cgi/content/full/102/1/e7
   PubMed Web of Science ®Google Scholar
• JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Circul J. 2014;78(10):2521–2562.
   PubMed Web of Science ®Google Scholar
• Scheinfeld NS, Jones EL. Kawasaki disease [Internet]. New York: Medscape; c 1994–2017. [updated 2016 Oct 25; cited 2017 Jan 17]. Available from: http://emedicine.medscape.com/article/965367-overview
   Google Scholar
• Son MB, Sundel R. Kawasaki Disease. In: Petty R, Lindslay C, Laxter R, Wadderburn L, editors. Textbook of pediatric rheumatology. Philadelphia (PA): Elsevier; 2016. p. 467–483.
   Google Scholar
• Baker A, Newburger J. Kawasaki disease. Circulation. 2008;118:e110–e112.
   PubMed Web of Science ®Google Scholar
• Barclay L, Vega C. American heart association revises guidelines on Kawasaki disease. Medscape. 2004 Oct 25; [cited 2017 May 17]. Available from:http://www.medscape.org/viewarticle/491960
   Google Scholar
• Scuccimarri R. Kawasaki disease. Ped Clin North Am. 2012;59(2):425–445.
   PubMed Web of Science ®Google Scholar
• Sleeper LA, Minich L, McCrindle B, et al. Valuation of Kawasaki disease risk scoring systems for intervenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–835.
   PubMed Web of Science ®Google Scholar
• Koyanagi H, Yanagawa H, Nakamura Y, et al. Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan. Acta Paediatr. 1997;86(6):613–619.
   PubMed Web of Science ®Google Scholar
• Eleftheriou D, Levin M, Shingadia D, et al. Management of Kawasaki disease. Arch Dis Child. 2014;99:74–83.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. The anti-inflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007;204:11–15.
   PubMed Web of Science ®Google Scholar
• Wood LE, Tulloh RM. Diagnosis and management of Kawasaki disease in children. Pediatrics Child Health. 2007;18(2):70–74.
   Google Scholar
• Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 1994;89:916–922.
   PubMed Web of Science ®Google Scholar
• Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, american heart association. Pediatrics. 2004;114(6):1708–1733.
   PubMed Web of Science ®Google Scholar
• Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125(2):234–241.
   PubMed Web of Science ®Google Scholar
• Lin MT, Sun LC, Wu ET, et al. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy. Arch Dis Child. 2015;100(6):542–547.
   PubMed Web of Science ®Google Scholar
• Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulines. Clin Exp Immunol. 1994;97(Suppl 1):79–83.
   PubMed Web of Science ®Google Scholar
• Michihata N, Matsui H, Fushimi K, et al. Guideline-concordant treatment of Kawasaki disease with immunoglobulin and aspirin and the incidence of coronary artery aneurysm. Clin Pediatr (Phila). 2015;54:1076–1080.
   PubMed Web of Science ®Google Scholar
• Vierucci F, Azzarelli A, Gualtierotti R, et al. Changing management of Kawasaki disease. J Compr Ped [Internet]. 2014 [cited 2017 May 8];5:e19519. Available from:https://doi.org/10.17795/compreped-19519
   Google Scholar
• Shrestha S, Wiener HW, Olson AK, et al. Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease. J Allergy Clin Immunol. 2011;128(3):677–680.
   PubMed Web of Science ®Google Scholar
• Telcharova-Mihaylovska A, Stefanov S, Nikolova I. Kawasaki disease and acute haemolytic anaemia after two IVIG infusions. Biotechnol Biotechnolog Equip. 2016;30(3):448–452.
   Web of Science ®Google Scholar
• Suzuki A, Yamagishi M, Kimura K, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol. 1996;27:291–296.
   PubMed Web of Science ®Google Scholar
• Mitani Y, Okuda Y, Shimpo H, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation. 1997;96:454–461.
   PubMed Web of Science ®Google Scholar
• Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children: Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994;89:258–265.
   PubMed Web of Science ®Google Scholar
• Xie L, Wang R, Huang M, et al. Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease. Cardiovasc Ultrasound. 2015 [cited 2017 May 17];14:3. DOI: 10.1186/s12947-016-0046-7
   Web of Science ®Google Scholar
• Yonesaka S, Nakada T, Sunagawa Y, et al. Endomyocardial biopsy in children with Kawasaki disease. Acta Paediatr Jpn. 1989;31:706–711.
   PubMedGoogle Scholar